Advertisement

Effects of modulating Ca2+ entry and activating prejunctional receptors on facilitation of excitatory junction potentials in the guinea-pig vas deferens in vitro

  • Todd A. Hardy
  • James A. Brock
Original Article

Abstract.

This study investigated the effects of changing the extracellular Ca2+ concentration on facilitation of excitatory junction potential (EJP) amplitude during trains of 20 stimuli at 1 Hz at sympathetic neuroeffector junctions in the guinea-pig vas deferens. These effects were compared with those of Ca2+ channel blockers and agents which act at prejunctional receptors to increase or decrease neurotransmitter release. In these experiments, α-adrenoceptor-mediated autoinhibition of neurotransmitter release was blocked by the α-adrenoceptor antagonist, phentolamine (1 µM).

Varying the extracellular Ca2+ concentration (0.75–6 mM) changed the amplitude of EJPs without affecting the maximum level of facilitation during the trains of stimuli. Reductions in Ca2+ concentration (from 2 mM) were associated with a slowing in the rate of development of facilitation. The Ca2+ channel antagonists, Cd2+ (2 µM and 5 µM) and ω-conotoxin GVIA (10 nM), and agents which act at prejunctional receptors to reduce neurotransmitter release, adenosine (100 µM and 1000 µM) and prostaglandin E2 (PGE2; 0.1 nM and 1 nM), produced similar effects to those of lowering the extracellular Ca2+ concentration. Raising the extracellular Ca2+ concentration (from 2 mM) increased the rate of development of facilitation. Angiotensin II (AII; 0.5 µM) produced similar effects to raising extracellular Ca2+. However, isoprenaline (1 µM), while increasing EJP amplitude, reduced the maximum level of facilitation and was without effect on the rate of development of facilitation.

In the guinea-pig vas deferens EJPs are produced by neurally released ATP. Thus, the findings support the idea that adenosine, PGE2 and AII change ATP release by modifying Ca2+ entry into the nerve terminal. However, the effects of isoprenaline may not solely be accounted for by modifications in Ca2+ entry.

Neurotransmitter release Sympathetic nerves Vas deferens Electrophysiology Excitatory junction potential Purinergic transmission Prejunctional receptors Calcium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2001

Authors and Affiliations

  • Todd A. Hardy
    • 1
  • James A. Brock
    • 1
  1. 1.Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia

Personalised recommendations